Skip to main content
SUMOylation as a therapeutic target in inflammatory bowel diseases and sepsis

SUMOylation as a therapeutic target in inflammatory bowel diseases and sepsis

Unmet Need Inflammatory Bowel Disease (IBD) affects between 2.4 – 3.1 million people in the USA alone, with significant risks of complications such as sepsis. Chronic inflammation from IBD results in severe intestinal tissue damage,…

Read More

A method of treating and preventing gastrointestinal disorders

A method of treating and preventing gastrointestinal disorders

Unmet Need Gastrointestinal disorders such as inflammatory bowel disease, constipation, and intestinal pseudo-obstruction have been estimated to affect more than 40% of adults worldwide. These disorders are often associated with alterations in gut microbiota, which…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us